Armando D. Cunha-Silva
Belo Horizonte, MG, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Intravitreal implants for drug delivery: clinical efficacy, safety, and translational perspectives.
Journal: Expert opinion on drug delivery
Published: February 10, 2026
Correction: Assessment of AAV/polyketal chimeric nanoparticles for ocular gene transduction using an animal model.
Journal: Drug delivery and translational research
Published: January 16, 2026
Assessment of AAV/polyketal chimeric nanoparticles for ocular gene transduction using an animal model.
Journal: Drug delivery and translational research
Published: April 16, 2025
Acetazolamide-loaded intravitreal implants for the treatment of glaucoma: formulation, physicochemical characterization and assessment of in vitro and in vivo safety.
Journal: International journal of pharmaceutics
Published: February 04, 2025
Two Decades of Research in Drug Delivery Systems for the Treatment of Diseases of the Posterior Segment of the Eye.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: August 29, 2024
Corneal Permeability and Uptake of Twenty-Five Drugs: Species Comparison and Quantitative Structure-Permeability Relationships.
Journal: Pharmaceutics
Published: April 22, 2023
Efficacy and Safety Evaluation of Mometasone Furoate in Treating Ocular Inflammation.
Journal: Pharmaceutics
Published: November 30, 2022
Clinical outcomes of intravitreal treatment for ocular toxoplasmosis: systematic review and meta-analysis.
Journal: Revista da Sociedade Brasileira de Medicina Tropical
Published: November 03, 2022
In Vitro and In Vivo Effect of pH-Sensitive PLGA-TPGS-Based Hybrid Nanoparticles Loaded with Doxorubicin for Breast Cancer Therapy.
Journal: Pharmaceutics
Published: September 13, 2022
The Use of Polymer Blends in the Treatment of Ocular Diseases.
Journal: Pharmaceutics
Published: May 17, 2022
Low-dose melittin is safe for intravitreal administration and ameliorates inflammation in an experimental model of uveitis.
Journal: Current research in pharmacology and drug discovery
Published: January 21, 2022
Last Updated: 09/26/2026